Trince
Gent, BE · 1 known investors
Trince Bio develops photoporation, a cell transfection platform using pulsed laser light and photothermal nanosensitizers to deliver payloads into cells with minimal cellular damage. The platform serves researchers and clinicians needing gentle, high-yield cell transfection for gene editing, nucleic acids, proteins, and other therapeutic payloads.